Alert to US Physicians: DHEA, Widely Used as an OTC Androgen Supplement, May Exacerbate COVID-19

    December 2020 in “ Endocrine-related Cancer
    Jonathan W. Nyce
    Image of study
    TLDR The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.
    The document discusses the potential risks of DHEA (Dehydroepiandrosterone), an over-the-counter androgen supplement widely used in the US, in exacerbating COVID-19. DHEA induces the ACE-2 receptor and TMPRS22, key to the virus's entry and infection process, and inhibits glucose-6-phosphate dehydrogenase (G6PD), making G6PD-deficient cells more susceptible to coronavirus infection. The document suggests that DHEA may contribute to SARS-CoV-2-induced vascular endothelialitis, leading to multi-organ inflammatory reactions, especially in diabetic patients and those with G6PD deficiency. The authors recommend considering the suspension of over-the-counter availability of DHEA unless its safety can be proven in placebo-controlled, randomized, double-blind clinical trials.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 98 results

    Similar Research

    5 / 1000+ results
      Roles of Steroid Receptors in the Lung and COVID-19

      research Roles of Steroid Receptors in the Lung and COVID-19

      9 citations , July 2021 in “Essays in Biochemistry”
      Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.
      Male Sex Hormones, Aging, And Inflammation

      research Male Sex Hormones, Aging, And Inflammation

      60 citations , January 2023 in “Biogerontology”
      Adequate testosterone is crucial for men's health and quality of life, but its decline with age needs more research.
      COVID-19 and Hypopituitarism

      research COVID-19 and Hypopituitarism

      15 citations , August 2021 in “Reviews in endocrine and metabolic disorders”
      COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.
      Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      research Antiandrogens and Androgen Inhibitors in Dermatologic Treatments

      November 2020 in “Elsevier eBooks”
      Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.